Biliary Stents Market Report 2026

Biliary Stents Market Overview

• Biliary Stents market size has reached to $0.5 billion in 2025 • Expected to grow to $0.66 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Rising Incidence Of Pancreatic Cancer Fueling The Growth Of The Market Due To Increasing Need For Obstruction Relief And Supportive Cancer Care • Market Trend: Innovative Stent Offers Enhanced Flexibility And Patency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biliary Stents Market?

Biliary stents are small, tube-like devices inserted into the bile ducts to keep them open and ensure proper bile flow from the liver to the intestines. They are typically used to relieve blockages caused by conditions such as tumors, gallstones, or inflammation. Biliary stents prevent or alleviate bile duct obstruction, reducing symptoms such as jaundice and preventing liver damage. The main types of biliary stents are metal, polymer, and plastic. Metal stents are tubular devices made from alloys such as stainless steel, nitinol (nickel-titanium), cobalt-chromium, and platinum-chromium. They come in various designs, including single stent, double stent, and triple stent, and are used in procedures such as endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. These are applied in managing biliopancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and others, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Biliary Stents Market Growth Forecast?

The biliary stents market size is expected to see strong growth in the next few years. It will grow to $0.66 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to development of covered and partially covered metal stents, rising demand for biodegradable polymer stents, expansion of minimally invasive surgical procedures, increasing awareness of stent-related complications, integration of imaging and smart stent technologies. Major trends in the forecast period include increasing use of self-expandable metal stents (sems), rising adoption of biodegradable polymer stents, growth in endoscopic and minimally invasive procedures, expansion of biliary stent applications in pancreatic and gallstone treatments, enhanced focus on stent safety and patient outcomes.

Global Biliary Stents Market Segmentation

1) By Type: Metal, Polymer, Plastic 2) By Design: Single Stent, Double Stent, Triple Stent 3) By Procedure: Endoscopic Retrograde Cholangiopancreatography, Percutaneous Transhepatic Cholangiography 4) By Application: Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Structures, Gallstones, Other Applications 5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty clinics, Other End-Users Subsegments: 1) By Metal: Self-Expandable Metal Stents (SEMS), Covered Metal Stents, Uncovered Metal Stents, Partially Covered Metal Stents 2) By Polymer: Biodegradable Polymer Stents, Non-Biodegradable Polymer Stents 3) By Plastic: Straight Plastic Stents, Double Pigtail Plastic Stents, Multiple Side Hole Stents, Teflon Stents, Polyurethane Stents

What Is The Driver Of The Biliary Stents Market?

The rising incidence of pancreatic cancer is expected to propel the growth of the biliary stents market going forward. Pancreatic cancer refers to a type of cancer that begins in the tissues of the pancreas, an organ important for digestion and blood sugar regulation. The pancreatic cancer incidence is rising largely due to the aging population combined with the growing prevalence of risk factors such as obesity, diabetes, and smoking. Biliary stents support pancreatic cancer care by relieving bile duct obstructions, improving liver function, and reducing jaundice. They enhance patient comfort by enabling better bile flow, facilitating continued cancer treatment, and improving quality of life. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Therefore, the rising incidence of pancreatic cancer is driving the growth of the biliary stents industry.

Key Players In The Global Biliary Stents Market

Major companies operating in the biliary stents market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson & Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew Plc., W. L. Gore & Associates Inc., Nipro Corporation, Teleflex Incorporated, Cook Group, NuVasive Inc., Merit Medical Systems Inc., CONMED Corporation, Brainlab, Bard Peripheral Vascular Inc., Argon Medical Devices Inc., B Braun Melsungen AG, M.I Tech

Global Biliary Stents Market Trends and Insights

Major companies operating in the biliary stents market are focusing on developing advanced products, such as drug-eluting stents, to improve patient outcomes, enhance durability, and reduce complications like restenosis. Drug-eluting stents refer to specialized biliary stents coated with medication that is slowly released to prevent tissue overgrowth and blockages in the bile ducts. For instance, in July 2024, CGBIO, a South Korea-based medical device company, received Pharmaceuticals and Medical Devices Agency (PMDA) approval in Japan for biliary ARISTENT. It is designed to treat bile duct blockages, featuring a patented ‘HOOK & CROSS’ structure for enhanced flexibility and long-term patency. This stent adapts to the bile duct’s anatomy, reducing migration risk and improving patient comfort. It also incorporates an advanced drug-eluting coating to minimize inflammation and prolong stent patency, offering a more effective solution for biliary obstructions.

What Are Latest Mergers And Acquisitions In The Biliary Stents Market?

In January 2024, Olympus Corporation, a Japan-based medical technology company, acquired Taewoong Medical Co. Ltd. for $370 million. With this acquisition, Olympus aims to strengthen its global endoscopic device portfolio by adding Taewoong’s metallic stents, including biliary stents, enhancing its capabilities in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a South Korea-based company specializing in self-expandable metallic stents, including biliary stents.

Regional Outlook

North America was the largest region in the biliary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Biliary Stents Market?

The biliary stents market consists of sales of biliary stent systems, single-use and reusable devices, bioabsorbable stents, and stent delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.